A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

NCT01372150 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

340

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: desvenlafaxine succinate sustained release
DRUG: fluoxetine
DRUG: placebo

Sponsor

Pfizer